Pharmacogenetics in Potential Herb-Drug Interactions: Effects of Ginseng on CYP3A4 and CYP2C9 Allelic Variants

被引：1
作者：
Luu, Alice [1 ]
Foster, Brian C. [1 ]
McIntyre, Kristina L. [1 ]
Tam, Teresa W. [1 ]
Arnason, John T. [1 ]
机构：
[1] Therapeut Products Director Hlth Canada, Ottawa, ON, Canada
来源：
BIOLOGICAL ACTIVITY OF PHYTOCHEMICALS | 2011年 / 41卷
关键词：
POLYMORPHISMS; GINSENOSIDES; INHIBITION; WARFARIN; ENZYMES;
D O I：
10.1007/978-1-4419-7299-6_5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：59 / +
页数：2
相关论文
共 13 条
  • [1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    Aithal, GP
    Day, CP
    Kesteven, PJL
    Daly, AK
    [J]. LANCET, 1999, 353 (9154) : 717 - 719
  • [2] EVALUATION OF THE ERGOGENIC PROPERTIES OF GINSENG
    BAHRKE, MS
    MORGAN, WP
    [J]. SPORTS MEDICINE, 1994, 18 (04) : 229 - 248
  • [3] An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents
    Etheridge, Amy S.
    Black, Sherry R.
    Patel, Purvi R.
    So, James
    Mathews, James M.
    [J]. PLANTA MEDICA, 2007, 73 (08) : 731 - 741
  • [4] Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes
    Hao, Miao
    Zhao, Yuqing
    Chen, Peizhan
    Huang, He
    Liu, Hong
    Jiang, Hualiang
    Zhang, Ruiwen
    Wang, Hui
    [J]. PLOS ONE, 2008, 3 (07):
  • [5] He Nu, 2004, Am J Ther, V11, P206, DOI 10.1097/00045391-200405000-00009
  • [6] Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity
    Henderson, GL
    Harkey, MR
    Gershwin, ME
    Hackman, RM
    Stern, JS
    Stresser, DM
    [J]. LIFE SCIENCES, 1999, 65 (15) : PL209 - PL214
  • [7] Probable interaction between warfarin and ginseng
    Janetzky, K
    Morreale, AP
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (06) : 692 - 693
  • [8] Clinical consequences of cytochrome P4502C9 polymorphisms
    Kirchheiner, J
    Brockmöller, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) : 1 - 16
  • [9] Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes
    Liu, Yong
    Zhang, Jiang-Wei
    Li, Wei
    Ma, Hong
    Sun, Jie
    Deng, Mai-Cun
    Yang, Ling
    [J]. TOXICOLOGICAL SCIENCES, 2006, 91 (02) : 356 - 364
  • [10] PHENELZINE AND THE DREAM MACHINE - RAMBLINGS AND REFLECTIONS
    SHADER, RI
    GREENBLATT, DJ
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1985, 5 (02) : 65 - 65
12